M&R Capital Management Inc Edwards Lifesciences Corp Transaction History

M&R Capital Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 05, 2021	SELL	$71.69 - $91.23 $34,411 - $43,790	-480 Closed	0 $0
Q2 2020 Jul 01, 2020	BUY	$57.54 - $76.95 $18,412 - $24,624	320 Added 200.0%	480 $33,000
Q2 2019 Jul 24, 2019	BUY	$55.74 - $64.41 $8,918 - $10,305	160 New	160 $29,000
Q2 2018 Aug 08, 2018	SELL	$42.45 - $51.3 $0 - $0	0 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$37.19 - $47.45 $743 - $949	-20 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	20	20 $2,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on M&R Capital Management Inc with notifications on news.